COMPASS Pathways plc (COMPASS Pathways Plc - American) Aktie
CMPS
Pre-market$13.33-0.86 (-6.06%)
Pre-Market:$13.32-0.01 (-0.08%)
Chart wird geladen...
COMPASS Pathways Plc - American
Market Cap
$1,798,874,368
Eröffnung14.16
Hoch14.36
Tief13.30
Volumen5.37M
P/EN/A
Marktkapitalisierung1.8B
52-Wochen-Hoch14.76
52-Wochen-Tief2.25
Durchschn. Volumen4.02M
DividendeN/A
Beta2.40
EPS-3.14
Über COMPASS Pathways plc (COMPASS Pathways Plc - American) Aktie
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Unternehmensinformationen
Börse: NasdaqGS (NMS)
Sektor: Sundhed
Branche: Sundheds- og plejefaciliteter
Adresse:
33 Broadwick Street
W1F 0DQ London, United Kingdom
W1F 0DQ London, United Kingdom
Telefon: + 44 716 6766461
Webseite: https://compasspathways.com
Analystenempfehlungen
Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.
Anbefaling:1.33 - Stærk køb
Niedrigstes Kursziel
8.00
↓ 40.0%
Durchschnittliches Kursziel
22.20
↑ 66.5%
Median Kursziel
18.00
↑ 35.0%
Höchstes Kursziel
70.00
↑ 425.1%